Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Invested Capital (2016 - 2025)

Historic Invested Capital for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $198.9 million.

  • Medifast's Invested Capital fell 532.53% to $198.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $198.9 million, marking a year-over-year decrease of 532.53%. This contributed to the annual value of $198.9 million for FY2025, which is 532.53% down from last year.
  • Medifast's Invested Capital amounted to $198.9 million in Q4 2025, which was down 532.53% from $214.7 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Invested Capital registered a high of $216.0 million during Q1 2022, and its lowest value of $150.5 million during Q3 2022.
  • In the last 5 years, Medifast's Invested Capital had a median value of $200.2 million in 2023 and averaged $193.6 million.
  • Per our database at Business Quant, Medifast's Invested Capital surged by 6677.72% in 2021 and then crashed by 2342.52% in 2022.
  • Quarter analysis of 5 years shows Medifast's Invested Capital stood at $202.5 million in 2021, then fell by 23.43% to $155.0 million in 2022, then grew by 29.95% to $201.5 million in 2023, then rose by 4.28% to $210.1 million in 2024, then fell by 5.33% to $198.9 million in 2025.
  • Its last three reported values are $198.9 million in Q4 2025, $214.7 million for Q3 2025, and $216.0 million during Q2 2025.